Feedback / Questions
FT-002 - Hofseth Biocare
https://www.manilatimes.net/2025/09/17/tmt-newswire/globenewswire/hofseth-biocare-asa-aecorbio-secures-a-further-15m-at-a-30m-valuation-for-ongoing-ft-002a-peptide-development-in-prostate-cancer/2185708
Sep 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next